Displaying 521 - 530 of 657
This guideline was developed by a multidisciplinary task force and uses the GRADE framework to provide evidence-based recommendations regarding cardiovascular risk assessment, benefits and harms of newer medications, and treatment goals with a focus on patient-important outcomes.
DOI: 10.1016/j.eprac.2024.09.016
Read Guideline
Commentary
Review highlights and commentary from practicing endocrinologist and immediate past chair of the AACE CPG Oversight Committee, Dr. Ricardo Correa, on…
moreBeyond LDL-C: Optimizing ASCVD Risk Reduction in Diabetes Care empowers endocrinologists and frontline clinicians to tackle the substantial residual cardiovascular risk that persists in adults with type 2 diabetes (T2D) despite optimal glycemic control. You’ll explore how diabetes drives long-term low-density lipoprotein cholesterol (LDL-C) exposure and atherosclerotic cardiovascular disease (ASCVD) progression, learn to implement proactive risk stratification and post-event LDL-C screening, and master guideline-recommended targets through personalized lipid-lowering strategies. By…
moreWe are pleased to announce that the
Endocrine Practice (EP) 2025 CiteScore* has risen to 7.5 (up from 7.0 in 2024), moving us up from #61 to #56 in the Scopus category “Endocrinology, Diabetes, and Metabolism.” This improvement underscores the growing influence and reach of AACE’s flagship journal. In addition, the 2025 Journal Impact Factor (JIF) for EP is 4.4, ranked 59th out of 198 endocrinology and metabolism titles, firmly within the top 30% of its category.We extend our…
moreThe Cardiometabolic and Lipids DSN is a collaborative community of AACE members dedicated to advancing the prevention, diagnosis, and management of cardiometabolic diseases, dyslipidemia, obesity, metabolic syndrome, and cardiovascular risk reduction. Our members represent a diverse group of endocrinologists and healthcare professionals who share a commitment to improving patient outcomes through evidence-based, patient-centered care. As the burden of cardiometabolic disease continues to rise globally, our mission is to provide timely, practical, and scientifically rigorous resources that…
more
As GLP-1 receptor agonists and other obesity pharmacotherapies become increasingly prescribed, clinicians need practical, evidence-based tools to guide nutritional counseling. Dietary quality becomes especially critical when caloric intake is reduced — nutritional needs must still be fully met.
Background
Understanding the Nutritional Impact of Obesity Medications
Obesity affects an estimated 90 million people in the United States. Between 1999 and 2020, adult obesity rates rose from 30.5% to 41.9%, with severe obesity increasing from 4.7% to 9.2%. Originally developed for type 2…
more
Dear AACE Community,
As we enter the second half of 2026, I want to reflect on the momentum we built throughout June and share several important engagements taking place in the weeks ahead. Across scientific meetings, advocacy efforts, leadership development, and global education, AACE continues to create opportunities to advance our mission of elevating the practice of clinical endocrinology to improve global health.
June Highlights
- American Diabetes Association (ADA) Scientific Sessions, New Orleans, Louisiana (June 5–8): Last month, I attended the…
moreThrough an open-air hallway sheltered by a slanted aluminum awning, we briskly stride past the male medical ward, radiology department, and billing services until we reach the strikingly white door of the intensive care unit (ICU). A whisper of warm breeze sneaks into the vestibule with us as the door swings shut, and we quickly slip into one-size splashproof shoes before entering the two-bed ICU. Here, the lone pump-based infusion set at this hospital looms over a patient’s bed; he is ventilated and on pressors.
In the adjacent (and only other) bed lies our patient, belly ballooning in…
moreFellow of the American Association of Clinical Endocrinology (FACE®)
The FACE Application Period is Closed.
Submit Your Fellow of the American Association of Clinical Endocrinology (FACE) Application for Review by the Experts!
July 1 – August 30, 2024
If you are interested in applying for the FACE distinction but are not sure if you meet all the
FACE Criteria, this review process will be valuable to you. The FACE mentor will review your CV and certifications to verify that you meet the FACE criteria and that you satisfy the…
moreA preliminary slate of candidates for the election of Officer positions for a one-year (1) term, five (5) open positions on the Board of Directors for election to a three-year (3) term (2019-2022) and one (1) open position on the Board of Directors for a one-year (1) term (2019-2020) to fill the unexpired term of Dr. Sethu Reddy, who was elected Secretary in 2018, was sent to the membership via email/fax on December 28.
In accordance with AACE Bylaws,* nominations may also be submitted by petition from the membership, provided that the candidate otherwise qualifies under the Bylaws, and…
more
